Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging

被引:3
|
作者
Anisimov, VN
Khavinsov, VK
Alimova, IN
Provintsiali, M
Manchini, R
Francheski, K
机构
[1] Russian Acad Med Sci, St Petersburg Inst Bioregulat & Gerontol, NW Div, Moscow 109801, Russia
[2] Russian Minist Hlth, NN Petrov Inst Oncol, Dept Carcinogenesis & Oncogerontol, St Petersburg, Russia
[3] Italian Natl Res Ctr Aging, Ancona, Italy
关键词
transgenic mice; HER-2/neu; breast cancer; peptides; Epithalon; Vilon;
D O I
10.1023/A:1015555023692
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Female transgenic FVB mice carrying breast cancer gene HER-2/neu were monthly injected with Vilon or Epithalon (1 mug subcutaneously for 5 consecutive days) starting from the 2nd month of life. Epithalon markedly inhibited neoplasm development: the maximum size of breast adenacarcinomas was 33% lower than in the control (p<0.05). The intensity of HER-2/neu mRNA expression in breast tumors of Epithalon-treated mice was 3.7 times lower than in control animals. These results indicate that Epithalon inhibited breast tumor development in transgenic mice, which is probably related to suppression of HER-2/neu expression.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [1] Epithalon Inhibits Tumor Growth and Expression of HER-2/neu Oncogene in Breast Tumors in Transgenic Mice Characterized by Accelerated Aging
    V. N. Anisimov
    V. Kh. Khavinsov
    I. N. Alimova
    M. Provintsiali
    R. Manchini
    K. Francheski
    [J]. Bulletin of Experimental Biology and Medicine, 2002, 133 : 167 - 170
  • [2] Epithalon decelerates aging and suppresses development of breast, adenocarcinomas in transgenic HER-2/neu mice
    Anisimov, VN
    Khavinson, VK
    Alimova, IN
    Semchenko, AV
    Yashin, AI
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2002, 134 (02) : 187 - 190
  • [3] Epithalon Decelerates Aging and Suppresses Development of Breast Adenocarcinomas in Transgenic HER-2/neu Mice
    V. N. Anisimov
    V. Kh. Khavinson
    I. N. Alimova
    A. V. Semchenko
    A. I. Yashin
    [J]. Bulletin of Experimental Biology and Medicine, 2002, 134 : 187 - 190
  • [4] HER-2/neu is a tumor rejection target in tolerized HER-2/neu transgenic mice
    Reilly, RT
    Gottlieb, MBC
    Ercolini, AM
    Machiels, JPH
    Kane, CE
    Okoye, FI
    Muller, WJ
    Dixon, KH
    Jaffee, EM
    [J]. CANCER RESEARCH, 2000, 60 (13) : 3569 - 3576
  • [5] Analysis of HER-2/neu Receptor Expression and the Level of Neuronal Apoptosis in HER-2/neu Transgenic Mice during Aging
    Solovyova, A. S.
    Sokolova, Yu O.
    Anisimov, V. N.
    Bazhanova, E. D.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 167 (04) : 512 - 515
  • [6] Analysis of HER-2/neu Receptor Expression and the Level of Neuronal Apoptosis in HER-2/neu Transgenic Mice during Aging
    A. S. Solovyova
    Yu. O. Sokolova
    V. N. Anisimov
    E. D. Bazhanova
    [J]. Bulletin of Experimental Biology and Medicine, 2019, 167 : 512 - 515
  • [7] Metformin decelerates aging and development of mammary tumors in HER-2/neu transgenic mice
    Anisimov, VN
    Egormin, PA
    Bershtein, LM
    Zabezhinskii, MA
    Piskunova, TS
    Popovich, IG
    Semenchenko, AV
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 139 (06) : 721 - 723
  • [8] Metformin Decelerates Aging and Development of Mammary Tumors in HER-2/neu Transgenic Mice
    V. N. Anisimov
    P. A. Egormin
    L. M. Bershtein
    M. A. Zabezhinskii
    T. S. Piskunova
    I. G. Popovich
    A. V. Semenchenko
    [J]. Bulletin of Experimental Biology and Medicine, 2005, 139 : 721 - 723
  • [9] HER-2/neu oncogene expression in advanced breast cancer
    Krogerus, LA
    Leivonen, M
    [J]. CANCER DETECTION AND PREVENTION, 2001, 25 (01): : 1 - 7
  • [10] HER-2/NEU ONCOGENE EXPRESSION AND PROLIFERATION IN BREAST CANCERS
    BACUS, SS
    RUBY, SG
    WEINBERG, DS
    CHIN, D
    ORTIZ, R
    BACUS, JW
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1990, 137 (01): : 103 - 111